Kala Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000486818

Total reported 2019–2025

$7.59M

#578 of 2,960 reporting companies — 0% of all reported industry payments

$3.52M in general payments across 36,765 records, plus $4.07M in research funding across 748 records.

How it breaks down

General payments $3,515,212

Research funding $4,070,644

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.